心肌和脏的宁-氨酶系统酶活性在狗
Emma C Weitzhandler1, Marisa K Ames1, Machelle D Wilson2
1Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California, USA.
Journal of veterinary internal medicine
|July 2, 2025
概括
瑞宁-血管酶系统酶在狗心脏和脏组织中保持活跃,死后24小时以上. 这项研究量化了狗的组织宁-血管酶系统酶活性,即使在延迟结的情况下也显示出可靠的结果.
科学领域:
- 兽医病理学 兽医病理学
- 心血管研究研究心血管研究
- 脏生理学 脏生理学
背景情况:
- 精确量化组织氨酸 - ангиотензин系统 (RAS) 对于了解心血管和脏健康至关重要.
- 评估组织RAS活性的现有方法面临局限性,需要新的方法.
研究的目的:
- 确定死后犬组织中心肌和脏氨酸-血管新生素系统酶的活性.
- 评估死后间隔对组织RAS酶活性测量的可靠性的影响.
主要方法:
- 分析了15只患有心感染的特种犬和22只客户拥有的狗的心肌和脏组织.
- 组织样本是在死后的不同时间收集的 (20分钟内到中位数为21.9小时).
- 通过将同质化组织与血管素I或II化,评估酶活性,在不同的条件下测量产品形成.
主要成果:
- 列宁-血管酶系统酶在所有分析的死后犬组织中都表现出活性.
- ангиотензин转化酶是 ангиотензин II 形成的主要贡献者 (>88%).
- 配对样本分析表明,即使在延迟冷 (死后长达24小时) 时,也可靠地测量了酶活性.
结论:
- 狗心肌和脏组织在死后24小时以上保持活跃的氨酸- ангиотензин系统酶.
- 这些发现支持使用死后组织进行可靠的氨酸 - 血管新生素系统研究.
- 这项研究为在各种生理和病理条件下进一步研究组织RAS提供了基础.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
524
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
524
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
905
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
905
Antihypertensive Drugs: Direct Renin Inhibitors
845
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
845
Hormonal Regulation
33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
Heart Failure II: Pathophysiology
54
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
54
Antihypertensive Drugs: Angiotensin II Receptor Blockers
942
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
942


